Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | September 04, 2024 |
| PDB ID | UniProt ID ▼ | Title | Descriptor |
|---|---|---|---|
| 6V19 | P13760 | immune receptor complex | |
| 6V18 | P13760 | immune receptor complex | |
| 1D5M | P13760 | X-RAY CRYSTAL STRUCTURE OF HLA-DR4 COMPLEXED WITH PEPTIDE AND SEB | |
| 1J8H | P13760 | Crystal Structure of a Complex of a Human alpha/beta-T cell Receptor, Influenza HA Antigen Peptide, and MHC Class II Molecule, HLA-DR4 | |
| 2SEB | P13760 | X-RAY CRYSTAL STRUCTURE OF HLA-DR4 COMPLEXED WITH A PEPTIDE FROM HUMAN COLLAGEN II | |
| 4MCY | P13760 | Immune Receptor | |
| 4MCZ | P13760 | Immune Receptor | |
| 4MD0 | P13760 | Immune Receptor | |
| 4MD4 | P13760 | Immune Receptor | |
| 4MD5 | P13760 | Immune Receptor | |
| 4MDI | P13760 | Immune Receptor | |
| 4MDJ | P13760 | Immune Receptor | |
| 4Y19 | P13760 | immune complex | |
| 4Y1A | P13760 | immune complex | HLA-DRA, HLA-DRB1.0401, ProinsulinC19 , FS17_alpha, FS17_beta |
| 6V13 | P13760 | immune receptor complex | |
| 1DLH | P13758 | CRYSTAL STRUCTURE OF THE HUMAN CLASS II MHC PROTEIN HLA-DR1 COMPLEXED WITH AN INFLUENZA VIRUS PEPTIDE | HLA-DR1 (DRA, DRB1 0101) HUMAN CLASS II HISTOCOMPATIBILITY PROTEIN (EXTRACELLULAR DOMAIN) COMPLEXED WITH ANTIGENIC PEPTIDE |
| 4ATV | P13738 | STRUCTURE OF A TRIPLE MUTANT OF THE NHAA DIMER, CRYSTALLISED AT LOW PH | |
| 4AU5 | P13738 | Structure of the NhaA dimer, crystallised at low pH | |
| 2BRS | P13727 | EMBP Heparin complex | |
| 7Y5N | P13727 | Structure of 1:1 PAPP-A.ProMBP complex(half map) | |
| 1DAN | P13726 | Complex of active site inhibited human blood coagulation factor VIIA with human recombinant soluble tissue factor | BLOOD COAGULATION FACTOR VIIA, SOLUBLE TISSUE FACTOR, D-PHE-PHE-ARG-CHLOROMETHYLKETONE (DFFRCMK) WITH CHLOROMETHYLKETONE REPLACED BY A METHYLENE GROUP, METHYLENE GROUP |
| 1FAK | P13726 | HUMAN TISSUE FACTOR COMPLEXED WITH COAGULATION FACTOR VIIA INHIBITED WITH A BPTI-MUTANT | |
| 1J9C | P13726 | Crystal Structure of tissue factor-factor VIIa complex | |
| 1W0Y | P13726 | tf7a_3771 complex | |
| 1W2K | P13726 | tf7a_4380 complex | |
| 1WQV | P13726 | Human Factor Viia-Tissue Factor Complexed with propylsulfonamide-D-Thr-Met-p-aminobenzamidine | |
| 1WSS | P13726 | Human Factor Viia-Tissue Factor in Complex with peptide-mimetic inhibitor that has two charged groups in P2 and P4 | |
| 1WTG | P13726 | Human Factor Viia-Tissue Factor Complexed with ethylsulfonamide-D-biphenylalanine-Gln-p-aminobenzamidine | |
| 1WUN | P13726 | Human Factor Viia-Tissue Factor Complexed with ethylsulfonamide-D-Trp-Gln-p-aminobenzamidine | |
| 1WV7 | P13726 | Human Factor Viia-Tissue Factor Complexed with ethylsulfonamide-D-5-propoxy-Trp-Gln-p-aminobenzamidine | Coagulation factor VII (E.C.3.4.21.21), Tissue factor |
| 2A2Q | P13726 | Complex of Active-site Inhibited Human Coagulation Factor VIIa with Human Soluble Tissue Factor in the Presence of Ca2+, Mg2+, Na+, and Zn2+ | |
| 2AER | P13726 | Crystal Structure of Benzamidine-Factor VIIa/Soluble Tissue Factor complex. | |
| 2B8O | P13726 | Crystal Structure of Glu-Gly-Arg-Chloromethyl Ketone-Factor VIIa/Soluble Tissue Factor Complex | Coagulation factor VII light chain, Coagulation factor VII heavy chain (E.C.3.4.21.21), Tissue factor, inhibitor |
| 2C4F | P13726 | crystal structure of factor VII.stf complexed with pd0297121 | COAGULATION FACTOR VII PRECURSOR (E.C.3.4.21.21), TISSUE FACTOR PRECURSOR |
| 2EC9 | P13726 | Crystal structure analysis of human Factor VIIa , Souluble tissue factor complexed with BCX-3607 | |
| 2FIR | P13726 | Crystal structure of DFPR-VIIa/sTF | Coagulation factor VII Light chain (E.C.3.4.21.21), Coagulation factor VII Heavy Chain (EC 3.4.21.21), Tissue factor |
| 2PUQ | P13726 | Crystal structure of active site inhibited coagulation factor VIIA in complex with soluble tissue factor | |
| 2ZP0 | P13726 | Human factor viia-tissue factor complexed with benzylsulfonamide-D-ile-gln-P-aminobenzamidine | |
| 2ZWL | P13726 | Human factor viia-tissue factor complexed with highly selective peptide inhibitor | |
| 2ZZU | P13726 | Human Factor VIIA-Tissue Factor Complexed with ethylsulfonamide-D-5-(3-carboxybenzyloxy)-Trp-Gln-p-aminobenzamidine | |
| 3ELA | P13726 | Crystal structure of active site inhibited coagulation factor VIIA mutant in complex with soluble tissue factor | |
| 3TH2 | P13726 | Mg2+ Is Required for Optimal Folding of the Gamma-Carboxyglutamic Acid (Gla) Domains of Vitamin K-Dependent Clotting Factors At Physiological Ca2+ | |
| 3TH3 | P13726 | Mg2+ Is Required for Optimal Folding of the Gamma-Carboxyglutamic Acid (Gla) Domains of Vitamin K-Dependent Clotting Factors At Physiological Ca2+ | |
| 3TH4 | P13726 | Mg2+ Is Required for Optimal Folding of the Gamma-Carboxyglutamic Acid (Gla) Domains of Vitamin K-Dependent Clotting Factors At Physiological Ca2+ | |
| 4IBL | P13726 | Rubidium Sites in Blood Coagulation Factor VIIa | |
| 4YLQ | P13726 | Crystal Structure of a FVIIa-Trypsin Chimera (FT) in Complex with Soluble Tissue Factor | |
| 4Z6A | P13726 | Crystal Structure of a FVIIa-Trypsin Chimera (YT) in Complex with Soluble Tissue Factor | |
| 4ZMA | P13726 | Crystal Structure of a FVIIa-Trypsin Chimera (ST) in Complex with Soluble Tissue Factor | |
| 6R2W | P13726 | Crystal structure of the super-active FVIIa variant VYT in complex with tissue factor | |
| 8CN9 | P13726 | Factor VII binding Fab of the bispecific antibody HMB-001 in complex with Factor VII |
